20/12/2021 (Agence Europe) – The Council of the EU gave the green light on Monday 20 December to the postponement of the implementation of Regulation 2017/746 on in vitro diagnostic medical devices (see EUROPE 12821/9) - also approved by the European Parliament last week (see EUROPE 12853/17). The European Commission welcomed the decision on Monday, recalling that the amending regulation adopted by the two institutions would not change any of the requirements of the original regulation. “It only changes the dates of application of some of these requirements for certain medical devices”, in particular high-risk devices, such as HIV or hepatitis tests (class D) and certain influenza tests (class C). For more details: https://bit.ly/3Fa2iFb (AC)